GRK5 Deficiency Accelerates β-Amyloid Accumulation in Tg2576 Mice via Impaired Cholinergic Activity

Dysfunction of G Protein-Coupled Receptor Kinases in Alzheimer’'s Disease

(2011) William Z. Suo et al.   TheScientificWorldJOURNAL

The secretases: enzymes with therapeutic potential in Alzheimer disease

(2010) Bart De Strooper et al.   Nature Reviews Neurology

GSK3 signalling in neural development

(2010) Eun-Mi Hur et al.   NATURE REVIEWS NEUROSCIENCE

GRK5 Deficiency Leads to Reduced Hippocampal Acetylcholine Level via Impaired Presynaptic M2/M4 Autoreceptor Desensitization

(2009) Jun Liu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Amyloid-  Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle

(2009) J.-E. Kang et al.   SCIENCE

G Protein-Coupled Receptors, Cholinergic Dysfunction, and A  Toxicity in Alzheimer's Disease

(2009) A. Thathiah et al.   Science Signaling

A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression

(2008) Carolyn L. Buller et al.   AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY

Augmented axonal defects and synaptic degenerative changes in female GRK5 deficient mice

(2008) Longxuan Li et al.   BRAIN RESEARCH BULLETIN

A Closer Look at α-Secretase

(2008) Rolf Postina   Current Alzheimer Research

GRK5 deficiency exaggerates inflammatory changes in TgAPPsw mice

(2008) Longxuan Li et al.   Journal of Neuroinflammation

M1 Muscarinic Agonists Target Major Hallmarks of Alzheimer’s Disease – The Pivotal Role of Brain M1 Receptors

(2008) Abraham Fisher   Neurodegenerative Diseases

Cholinergic treatments with emphasis on M1 muscarinic agonists as potential disease-modifying agents for Alzheimer’s disease

(2008) Abraham Fisher   Neurotherapeutics